Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease

OBJECTIVE: Deposition of Aβ-containing plaques as evidenced by amyloid imaging and CSF Aβ42 is an early indicator of preclinical Alzheimer disease (AD). To better understand their relationship during the earliest preclinical stages, we investigated baseline CSF markers in cognitively normal individu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Neurol
Main Authors: Vlassenko, Andrei G., McCue, Lena, Jasielec, Mateusz S, Su, Yi, Gordon, Brian A., Xiong, Chengjie, Holtzman, David M, Benzinger, Tammie LS, Morris, John C, Fagan, Anne M
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5016232/
https://ncbi.nlm.nih.gov/pubmed/27398953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.24719
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados